In the present study, overexpression of C14ORF166 was not only observed in HPV-positive cervical cancer cell lines, such as HeLa, SiHa, and CasKi, but also in the HPV-negative cervical cancer cell line C33A. This evidence concerns the gene RTRAF and cervical carcinoma.